Uttarakhand's Ayush Ministry issues notice to Patanjali over Coronil medicine

The day after Union Ayush Ministry issued noticed for stop advertising of Patanjali's 'Coronil and Swasari', the Ayush Ministry of Uttarakhand on Wednesday clarified that the licence issued was not to find a cure for coronavirus.

Dehradun: After the controversy over a new drug by Baba Ramdev’s Patanjali – Coronil, led to directives to stop its advertisement, the Uttarakhand Ayush Ministry on Wednesday clarified that the licence issued was not to find a cure for coronavirus.

The Ministry also said that the license was issued only for the production of immunity booster kits and fever medicine.

The Ayush Ministry said that it has taken cognizance of news media reports about Patanjali Ayurved Ltd, Haridwar developing Ayurvedic medicines for the treatment of COVID-19 and said the company has been asked to "stop advertising and publicising such claims till the issue is duly examined".

Speaking to ETV Bahrat, Uttarakhand's AYUSH Minister Harak Singh Rawat said, "Divya Pharmacy did not apply for the license of any kind of medicine related to Corona nor were they given any license in this regard. The license was issued only for immunity booster kits and fever medicine. But now that it has come to the attention of the AYUSH department, a notice will be issued to Divya Pharmacy."

"We only approved the license for immunity booster, cough, and fever. We'll issue them a notice asking how they got permission to make the kit (for COVID-19)," Rawat said.

Patanjali Ayurved on Tuesday had launched 'Coronil and Swasari' claiming it to be Ayurvedic cure for treating COVID-19 and had said clinical trials have shown favourable results.

Uttarakhand Ayush Ministry notices Patanjali over Coronil medicine

Dr YS Rawat, Joint Director State Medicinal Licensing Authority from Uttarakhand said, "The license was issued only for immunity booster kits and fever medicine. But now that it has come to the attention of the AYUSH department, a notice will be issued to Divya Pharmacy. If their reply is not satisfactory then their current licenses will be canceled.We will look into it and permission will be given after seeing the report."

On Tuesday, the Union Ayush Ministry had said that it has taken cognizance of news in the media about Ayurvedic medicines developed for the treatment of COVID-19 by Patanjali Ayurved Ltd, Haridwar and said the company has been asked to "stop advertising/publicising such claims till the issue is duly examined."